Search

everythinglearnresearchcommunity

for

Search:↓

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

New therapies are being developed that target integrin pathways to treat various diseases.

New therapies for rare skin diseases show promise but need more research.

Targeting Lgr5+ stem cells and Wnt signaling may effectively treat hair loss.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

SM04755 may be an effective topical treatment for psoriasis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

The new hydrogel helps heal burn wounds better than current options by reducing bacteria and inflammation.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

The assay effectively identifies compounds that affect immune cell activation.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Fermented grapeseed oil effectively repairs and protects chemically damaged hair.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.